+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Faropenem Sodium Market Research Report by Product (Purity:97%-99% and Purity:>99%), Type, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 5454934
  • Report
  • April 2022
  • Region: Global
  • 218 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • Alkem Laboratories Ltd.
  • DGpeptides Co., Ltd.
  • Kopran Ltd
  • Merck KGaA
  • NIKSAN HEALTHCARE
  • Rezcrit Healthcare
The Global Faropenem Sodium Market size was estimated at USD 182.38 million in 2021, USD 198.71 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 9.12% to reach USD 308.02 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Faropenem Sodium to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market was studied across Purity:97%-99% and Purity:>99%.
  • Based on Type, the market was studied across Injection Product and Table Product.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Faropenem Sodium market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Faropenem Sodium Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Faropenem Sodium Market, including Alkem Laboratories Ltd., Canagen Pharmaceuticals Inc, DGpeptides Co., Ltd., Glentham Life Sciences Ltd, Hangzhou Verychem Science and Technology Co., Ltd., Huanggang LUBAN Pharmaceutical Co., Ltd, Hunan Warrant Chiral Pharmaceutical Co., Ltd, Kopran Ltd, Lunan Pharmaceutical Group, MANUS AKTTEVA BIOPHARMA LLP, Merck KGaA, NIKSAN HEALTHCARE, Rezcrit Healthcare, Shandong Chenlong Pharmaceutical Co., Ltd, Shaoxing Hantai Pharmaceutical Co.Ltd, Shop RX Pharmacy, Shree Nath Life Sciences Pvt. Ltd., Sun Pharmaceutical Industries Ltd., Trumac Healthcare, and Viraj Pharmaceuticals Pvt. Ltd..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Faropenem Sodium Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Faropenem Sodium Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Faropenem Sodium Market?
4. What is the competitive strategic window for opportunities in the Global Faropenem Sodium Market?
5. What are the technology trends and regulatory frameworks in the Global Faropenem Sodium Market?
6. What is the market share of the leading vendors in the Global Faropenem Sodium Market?
7. What modes and strategic moves are considered suitable for entering the Global Faropenem Sodium Market?
Frequently Asked Questions about the Global Faropenem Sodium Market

What is the estimated value of the Global Faropenem Sodium Market?

The Global Faropenem Sodium Market was estimated to be valued at $182.4 Million in 2021.

What is the growth rate of the Global Faropenem Sodium Market?

The growth rate of the Global Faropenem Sodium Market is 9.1%, with an estimated value of $308.0 Million by 2027.

What is the forecasted size of the Global Faropenem Sodium Market?

The Global Faropenem Sodium Market is estimated to be worth $308.0 Million by 2027.

Who are the key companies in the Global Faropenem Sodium Market?

Key companies in the Global Faropenem Sodium Market include Alkem Laboratories Ltd., Canagen Pharmaceuticals Inc, DGpeptides Co., Ltd., Glentham Life Sciences Ltd, Hangzhou Verychem Science and Technology Co., Ltd., Huanggang LUBAN Pharmaceutical Co., Ltd, Hunan Warrant Chiral Pharmaceutical Co., Ltd, Kopran Ltd and MANUS AKTTEVA BIOPHARMA LLP.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Alkem Laboratories Ltd.
  • DGpeptides Co., Ltd.
  • Kopran Ltd
  • Merck KGaA
  • NIKSAN HEALTHCARE
  • Rezcrit Healthcare

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in the prevalence of bacterial infections
5.1.1.2. Rising use for the treatment of upper and lower respiratory infections, urinary tract infection, and skin infections
5.1.2. Restraints
5.1.2.1. Side effects of Faropenem sodium tablets
5.1.3. Opportunities
5.1.3.1. New product development and process improvement
5.1.3.2. Continuous research and development driven by the emergence of microbial resistance
5.1.4. Challenges
5.1.4.1. Risk of development of cross-resistance
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Faropenem Sodium Market, by Product
6.1. Introduction
6.2. Purity:97%-99%
6.3. Purity:>99%
7. Faropenem Sodium Market, by Type
7.1. Introduction
7.2. Injection Product
7.3. Table Product
8. Americas Faropenem Sodium Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Faropenem Sodium Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
10. Europe, Middle East & Africa Faropenem Sodium Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. Alkem Laboratories Ltd.
12.2. Canagen Pharmaceuticals Inc
12.3. DGpeptides Co., Ltd.
12.4. Glentham Life Sciences Ltd
12.5. Hangzhou Verychem Science and Technology Co., Ltd.
12.6. Huanggang LUBAN Pharmaceutical Co., Ltd
12.7. Hunan Warrant Chiral Pharmaceutical Co., Ltd
12.8. Kopran Ltd
12.9. Lunan Pharmaceutical Group
12.10. MANUS AKTTEVA BIOPHARMA LLP
12.11. Merck KGaA
12.12. NIKSAN HEALTHCARE
12.13. Rezcrit Healthcare
12.14. Shandong Chenlong Pharmaceutical Co., Ltd
12.15. Shaoxing Hantai Pharmaceutical Co.Ltd
12.16. Shop RX Pharmacy
12.17. Shree Nath Life Sciences Pvt. Ltd.
12.18. Sun Pharmaceutical Industries Ltd.
12.19. Trumac Healthcare
12.20. Viraj Pharmaceuticals Pvt. Ltd.
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL FAROPENEM SODIUM MARKET: DYNAMICS
FIGURE 2. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 3. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL FAROPENEM SODIUM MARKET SIZE, BY PRODUCT, 2027
FIGURE 5. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY PURITY:97%-99%, 2019-2027 (USD MILLION)
FIGURE 6. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY PURITY:97%-99%, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 7. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY PURITY:>99%, 2019-2027 (USD MILLION)
FIGURE 8. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY PURITY:>99%, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 10. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL FAROPENEM SODIUM MARKET SIZE, BY TYPE, 2027
FIGURE 12. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY INJECTION PRODUCT, 2019-2027 (USD MILLION)
FIGURE 13. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY INJECTION PRODUCT, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 14. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY TABLE PRODUCT, 2019-2027 (USD MILLION)
FIGURE 15. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY TABLE PRODUCT, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 16. AMERICAS FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 17. ARGENTINA FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 18. BRAZIL FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 19. CANADA FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 20. MEXICO FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 21. UNITED STATES FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 22. ASIA-PACIFIC FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 23. AUSTRALIA FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 24. CHINA FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 25. INDIA FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 26. INDONESIA FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 27. JAPAN FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 28. MALAYSIA FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 29. PHILIPPINES FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 30. SINGAPORE FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 31. SOUTH KOREA FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 32. TAIWAN FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 33. THAILAND FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 34. EUROPE, MIDDLE EAST & AFRICA FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 35. FRANCE FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 36. GERMANY FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 37. ITALY FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 38. NETHERLANDS FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 39. QATAR FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 40. RUSSIA FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 41. SAUDI ARABIA FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 42. SOUTH AFRICA FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 43. SPAIN FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 44. UNITED ARAB EMIRATES FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 45. UNITED KINGDOM FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 46. GLOBAL FAROPENEM SODIUM MARKET: FPNV POSITIONING MATRIX
FIGURE 47. GLOBAL FAROPENEM SODIUM MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 48. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL FAROPENEM SODIUM MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL FAROPENEM SODIUM MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY PURITY:97%-99%, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. AMERICAS FAROPENEM SODIUM MARKET SIZE, BY PURITY:97%-99%, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES FAROPENEM SODIUM MARKET SIZE, BY PURITY:97%-99%, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. ASIA-PACIFIC FAROPENEM SODIUM MARKET SIZE, BY PURITY:97%-99%, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA FAROPENEM SODIUM MARKET SIZE, BY PURITY:97%-99%, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 9. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY PURITY:>99%, BY REGION, 2019-2027 (USD MILLION)
TABLE 10. AMERICAS FAROPENEM SODIUM MARKET SIZE, BY PURITY:>99%, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES FAROPENEM SODIUM MARKET SIZE, BY PURITY:>99%, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. ASIA-PACIFIC FAROPENEM SODIUM MARKET SIZE, BY PURITY:>99%, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA FAROPENEM SODIUM MARKET SIZE, BY PURITY:>99%, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 14. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 15. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY INJECTION PRODUCT, BY REGION, 2019-2027 (USD MILLION)
TABLE 16. AMERICAS FAROPENEM SODIUM MARKET SIZE, BY INJECTION PRODUCT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 17. UNITED STATES FAROPENEM SODIUM MARKET SIZE, BY INJECTION PRODUCT, BY STATE, 2019-2027 (USD MILLION)
TABLE 18. ASIA-PACIFIC FAROPENEM SODIUM MARKET SIZE, BY INJECTION PRODUCT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 19. EUROPE, MIDDLE EAST & AFRICA FAROPENEM SODIUM MARKET SIZE, BY INJECTION PRODUCT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 20. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY TABLE PRODUCT, BY REGION, 2019-2027 (USD MILLION)
TABLE 21. AMERICAS FAROPENEM SODIUM MARKET SIZE, BY TABLE PRODUCT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 22. UNITED STATES FAROPENEM SODIUM MARKET SIZE, BY TABLE PRODUCT, BY STATE, 2019-2027 (USD MILLION)
TABLE 23. ASIA-PACIFIC FAROPENEM SODIUM MARKET SIZE, BY TABLE PRODUCT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. EUROPE, MIDDLE EAST & AFRICA FAROPENEM SODIUM MARKET SIZE, BY TABLE PRODUCT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 25. AMERICAS FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 26. ARGENTINA FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 27. BRAZIL FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 28. CANADA FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 29. MEXICO FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 30. UNITED STATES FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 31. ASIA-PACIFIC FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 32. AUSTRALIA FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 33. CHINA FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 34. INDIA FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 35. INDONESIA FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 36. JAPAN FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 37. MALAYSIA FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 38. PHILIPPINES FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 39. SINGAPORE FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 40. SOUTH KOREA FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 41. TAIWAN FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 42. THAILAND FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 43. EUROPE, MIDDLE EAST & AFRICA FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 44. FRANCE FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 45. GERMANY FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 46. ITALY FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 47. NETHERLANDS FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 48. QATAR FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 49. RUSSIA FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 50. SAUDI ARABIA FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 51. SOUTH AFRICA FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 52. SPAIN FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 53. UNITED ARAB EMIRATES FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 54. UNITED KINGDOM FAROPENEM SODIUM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 55. GLOBAL FAROPENEM SODIUM MARKET: SCORES
TABLE 56. GLOBAL FAROPENEM SODIUM MARKET: BUSINESS STRATEGY
TABLE 57. GLOBAL FAROPENEM SODIUM MARKET: PRODUCT SATISFACTION
TABLE 58. GLOBAL FAROPENEM SODIUM MARKET: RANKING
TABLE 59. GLOBAL FAROPENEM SODIUM MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 60. GLOBAL FAROPENEM SODIUM MARKET: MERGER & ACQUISITION
TABLE 61. GLOBAL FAROPENEM SODIUM MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 62. GLOBAL FAROPENEM SODIUM MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 63. GLOBAL FAROPENEM SODIUM MARKET: INVESTMENT & FUNDING
TABLE 64. GLOBAL FAROPENEM SODIUM MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 65. GLOBAL FAROPENEM SODIUM MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Alkem Laboratories Ltd.
  • Canagen Pharmaceuticals Inc
  • DGpeptides Co., Ltd.
  • Glentham Life Sciences Ltd
  • Hangzhou Verychem Science and Technology Co., Ltd.
  • Huanggang LUBAN Pharmaceutical Co., Ltd
  • Hunan Warrant Chiral Pharmaceutical Co., Ltd
  • Kopran Ltd
  • Lunan Pharmaceutical Group
  • MANUS AKTTEVA BIOPHARMA LLP
  • Merck KGaA
  • NIKSAN HEALTHCARE
  • Rezcrit Healthcare
  • Shandong Chenlong Pharmaceutical Co., Ltd
  • Shaoxing Hantai Pharmaceutical Co.Ltd
  • Shop RX Pharmacy
  • Shree Nath Life Sciences Pvt. Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Trumac Healthcare
  • Viraj Pharmaceuticals Pvt. Ltd.
Note: Product cover images may vary from those shown

Loading
LOADING...